<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="editorial" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Urol.</journal-id>
<journal-title>Frontiers in Urology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Urol.</abbrev-journal-title>
<issn pub-type="epub">2673-9828</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fruro.2023.1226476</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Urology</subject>
<subj-group>
<subject>Editorial</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Editorial: Challenging dogma: evolution in endourological techniques and management</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Yip</surname>
<given-names>Wesley</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1492009"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lebastchi</surname>
<given-names>Amir</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ghodoussipour</surname>
<given-names>Saum</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1031880"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center</institution>, <addr-line>New York, NY</addr-line>, <country>United States</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>USC Institute of Urology, University of Southern California</institution>, <addr-line>Los Angeles, CA</addr-line>, <country>United States</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Urology, Rutgers Robert Wood Johnson University Hospital</institution>, <addr-line>New Brunswick, NJ</addr-line>, <country>United States</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Katie Murray, University of Missouri, United States</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Catalin Andrei Bulai, Carol Davila University of Medicine and Pharmacy, Romania</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Wesley Yip, <email xlink:href="mailto:wesleyyipmd@gmail.com">wesleyyipmd@gmail.com</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>11</day>
<month>07</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>3</volume>
<elocation-id>1226476</elocation-id>
<history>
<date date-type="received">
<day>21</day>
<month>05</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>28</day>
<month>06</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Yip, Lebastchi and Ghodoussipour</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Yip, Lebastchi and Ghodoussipour</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="commentary-article" xlink:href="https://www.frontiersin.org/research-topics/30296" ext-link-type="uri">Editorial on the Research Topic <article-title>Challenging dogma: evolution in endourological techniques and management</article-title>
</related-article>
<kwd-group>
<kwd>endourology</kwd>
<kwd>HOLEP</kwd>
<kwd>holmium laser enucleation of the prostate</kwd>
<kwd>robotic surgery</kwd>
<kwd>ureteroscope</kwd>
</kwd-group>
<counts>
<fig-count count="0"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="0"/>
<page-count count="2"/>
<word-count count="708"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Endourology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>Urology is one of the most innovative surgical fields, but many dogmas continue to exist. Without appropriate challenge and discourse, these dogmas will perpetuate based on eminence rather than evidence. While the merits of certain approaches have become commonplace, such as ureteroscopy in lieu of open stone extraction, other debates rage on, including robotic versus open surgery. Indeed, the field of endourology was created from the desire to innovate and disseminate minimally invasive procedures with less morbidity but equal effectiveness. In line with the scope of Frontiers in Urology, which encourages novel research that challenges older existing principles, we organized this Research Topic to provide researchers the opportunity to challenge these dogmas and engage in robust academic discourse.</p>
<p>The first article by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fruro.2023.1080856">Kronstedt et&#xa0;al.</ext-link>, &#x201c;The role of bowel for minimally invasive treatment of stricture disease&#x201d; explores the various approaches to reconstruction of the urinary tract, from traditional open techniques, to difficult laparoscopic methods, to finding a balance between function and recovery with robotic assistance. While ileum has been utilized for upper tract reconstruction for over a century, there has been increasing usage of the appendix, especially on the right side, as either an interposition or an onlay graft. In the lower tract, buccal mucosa has been challenged by rectal mucosa harvests, which can be obtained transanally and reduce morbidity and enhance recovery in these patients.</p>
<p>In another article exploring stricture management, &#x201c;Allium stent as a curative treatment for benign ureteral strictures: Preliminary experience, surgical technique, and functional results&#x201d;, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fruro.2022.984719">Salciccia et&#xa0;al.</ext-link> report on the efficacy of dilation and temporary metal stent placement in lieu of chronic stent exchanges or invasive surgery and reconstruction. In an evaluation of 83 patients with a median stricture length of 2.5cm, their success rate with a median follow-up of 18 months is quite high &#x2013; certainly worth consideration, especially since the stent is able to be removed. We eagerly await an update in the future in regards to long-term durability.</p>
<p>In terms of BPH management, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fruro.2022.917195">Ganesh et&#xa0;al.</ext-link> question &#x201c;Effects of 5-alpha reductase inhibitors prior to Holmium Laser Enucleation of the prostate: Does increased adenoma density result in prolonged morcellation times?&#x201d;. As HoLEP becomes increasingly popular, and many of these men have suffered from BPH for an extended period of time and failed medical management, i.e. with 5-alpha reductase inhibitors, this question becomes quite salient for the endourologist and surgical planning. They perform a matched analysis in over 300 patients from an expert center to provide valuable data to the field.</p>
<p>Moving from benign to malignant, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fruro.2022.916259">Chien et&#xa0;al.</ext-link> provide a thorough review of &#x201c;The role of endoscopic management and adjuvant topical therapy for upper tract urothelial cancer&#x201d;. Given the significant morbidity and renal function loss with radical nephroureterectomy, percutaneous and ureteroscopic options are appealing in an often difficult to treat population. The disease is notoriously difficult to appropriately diagnose and stage, but numerous enhanced evaluation methods have emerged, including endoluminal ultrasonography, narrow-band imaging, photodynamic diagnosis, optical coherence tomography, and diagnostic confocal laser endomicroscopy. Tumor destruction methods are also advancing, with neodymium:yttrium-alumnium-garnet (YAG), holmium:YAG, and thulium:YAG lasers, cryoablation, and chemo/immunotherapeutic instillations.</p>
<p>Lastly, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fruro.2022.1018970">Di Gianfrancesco et&#xa0;al.</ext-link> ask the question, &#x201c;Could HoLEP change the further management of incidental prostate cancer?&#x201d;. Similar to incidental prostate cancer diagnosis at the time of transurethral resection of the prostate for presumed BPH, a subset of HoLEP patients will be newly diagnosed with prostate cancer. In this study, the oncologic outcomes of patients with prostate cancer diagnosis prior to, or as a result of, HoLEP are compared.</p>
<p>The goal of this Research Topic was to provide a forum in which authors could present original endourological research that helps to push the whole urological field forward, or at least provide data that can be debated. Many practice patterns are resistant to change, since stalwarts in the field have championed a technique for decades. Certain methods withstand the test of time, while others are replaced. We feel that these articles do indeed help to push the field forward, by providing food for thought and fodder for discussion.</p>
<sec id="s1" sec-type="author-contributions">
<title>Author contributions</title>
<p>All&#xa0;authors&#xa0;listed have made a substantial, direct, and intellectual&#xa0;contribution&#xa0;to the work and approved it for publication.</p>
</sec>
</body>
<back>
<sec id="s2" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
<p>The author(s) [SG, WY, AL] declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</p>
</sec>
<sec id="s3" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</back>
</article>